decrease was observed after the inhibition of NO synthesis. Histological examination of the kidney speciBackground. The pathophysiology of renal ischaemia, resulting in tubular cell injury and leading to acute mens showed that morphological changes were least in the rats treated with -arginine, when compared renal failure (ARF ), remains unclear. An everincreasing number of investigations focus on a possible with all other groups with ARF. Nevertheless, the lesions were most prominent in the -NAME+ARF role of nitric oxide (NO) in regulating circulation during ARF. In this context, we investigated the influ-group. In this group, the areas of corticomedullar necrosis were more widespread in comparison with ence of chronic stimulation or inhibition of NO synthesis, or both, on haemodynamic parameters, other groups, especially the -arginine group where only swelling of the proximal tubular cells was histology and plasma renin activity (PRA) after ischaemia-reperfusion injury of rat kidneys.
-Arginine reduces tubular cell injury in acute renal failure 1399 the drinking water, for 4 weeks for each of these two renal failure (ARF ) has yet to be elucidated. In substances (-NAME+-Arg+ARF group).
addition, the effects of NO on tubular morphology Group 6: and function are even less clearly understood. Hence, control rats (n=16) for the previous group of animals. studies on the role of NO synthesis in the regulation They received tap water for 8 weeks and then were of the renal blood flow and function are of high subjected to ARF (8 weeks-ARF group).
pathophysiological and therapeutic relevance. Besides, Blood pressure and body mass were measured once a week decreased synthesis or action of NO has been implicduring the 4-and 8-week course of treatment respectively. ated in some other diseases, such as hypertension, Before the induction of ischaemic ARF, endotheliumhypercholesterolaemia, diabetes or atherosclerosis [5] . dependent NO-mediated vasodilatation was examined using This study was designed to investigate whether chronic acetylcholine (Ach). Animals were anaesthetized using intramanipulation of the NO system (stimulation or peritoneal sodium pentobarbital (Nembutal ), 35 mg/kg b.m. inhibition of NO synthesis, or both) influences isch-The femoral artery (for blood pressure measurement) and aemia-reperfusion injury of rat kidneys, as seen femoral vein were cannulated and Ach was administered as through its haemodynamic and histopathological three i.v. boluses (0.2 mg/kg b.m., 0.4 mg/kg b.m. and 0.6 mg/kg b.m.). Boluses were separated by time intervals parameters.
allowing mean arterial pressure (MAP) to return to the Evidence is also emerging that NO contributes to baseline value. MAP was measured with a pressure transthe regulation of renin secretion. Therefore, this was ducer and recorded on a direct writing recorder. Vasodilative among our topics for investigation. A functional inter-response to Ach was calculated for each animal as a percentaction between NO and the renin-angiotensin system age of the MAP decline from its baseline value. After a might be expected since the effects of NO on systemic 30 -min wash-out interval and recovering of MAP, ARF was and renal haemodynamics appear to be opposite to induced. The right kidney was removed, and the left renal those of angiotensin II. It has been shown [6, 7] that artery was gently separated from the renal vein and clamped the plasma renin activity is increased in the initial with an atraumatic clamp for 45 min. The sham-operated stages of ARF. In this context, we examined whether rats were right nephrectomized. Immediately after surgery all rats were placed in individual metabolic cages and urine a long-term manipulation of the NO system changed was collected for the next 24 h. On the last experimental day the plasma renin activity (PRA) in the early stage of the treated animals continued to receive the same amount of post-ischaemic ARF.
the -NAME or -arginine as they did previously. The water and thus the drug intake were measured.
Subjects and methods

Haemodynamic measurements 24 h after reperfusion
Experiments were performed on adult male Wistar rats Haemodynamic parameters were measured after urine collec-(200-250 g). All animals were given standard food for labor-tion in anesthetized (35 mg/kg sodium pentobarbital ) rats: atory rats ( Veterinarski zavod, Zemun, Yugoslavia). Two sham-operated rats (n=10), 4 weeks-ARF group (n=14), separate baseline determinations of body mass and systolic -NAME+ARF group (n=8), -Arg+ARF group (n=8), blood pressure were made in all rats over a period of 2 -NAME+L-Arg+ARF group (n=8) and the respective weeks. Using a tail-cuff, pneumatic pulse detector and a control animals, 8 weeks-ARF group (n=8). Blood pressure direct recorder (Physiograph Four, Narco Bio-System, was measured directly through a femoral artery catheter Houston, TX, USA) systolic blood pressure was measured (PE-50, Clay-Adams, Parsippany, NJ, USA), using a lowindirectly. The animals were divided into six groups (as volume displacement transducer (P23 Db; Statham, Oxnard, follows) according to the drugs they were given during the CA, USA) and a direct writing recorder. MAP was obtained treatment period (of 4 or 8 weeks). All animals were eventu-by electronic integration. Cardiac output (CO) was deterally subjected to ARF, with the exception of the sham-mined using a previously described [8] modification of operated rats (see Fig. 1A outlining the experiment).
Coleman's application of the dye dilution technique [9] . Total peripheral resistance ( TPR) was calculated from MAP Group 1:
and CO (assuming that mean right atrial pressure is zero). sham-operated rats (n=18) received tap waterFor the blood-flow measurement the left renal artery was 100 ml/kg body mass (b.m.) for 4 weeks. gently separated. An ultrasonic flow probe (1RB, internal Group 2: diameter=1 mm) was placed around the artery to measure control rats (n=22) received the same amount of tap the total renal blood flow (RBF ), using a Transonic T106 water for 4 weeks and then ARF was induced (4 Small Animal Flowmeter (Transonic System Inc., Ithaca, weeks-ARF group).
NY, USA). Renal vascular resistance was calculated by Group 3:
dividing MAP by renal blood flow. -NAME (NG--arginine methyl ester; 10 mg/kg b.m./day), a NO synthesis inhibitor, was given in the drinking water for 4 weeks (-NAME+ARF group, Biochemical measurements and morphology n=16).
Group 4:
Urinary and plasma creatinine concentrations were determined using a Beckman 42 spectrophotometer. Concen--arginine (2 g/kg b.m./day), a substrate for NO was given in the drinking water for 4 weeks (-Arg+ARF trations of sodium (Na+) and potassium ( K+) in the plasma and urine were measured using a IL 943-flame photometer group, n=16). Group 5:
(Instrumentation Laboratory, Milan, Italy). A standard formula was used to calculate creatinine clearance. Fractional rats (n=16) were treated first with -NAME (10 mg/kg b.m./day) and then with -arginine (2 g/kg b.m./day) in excretion of electrolytes was calculated as a percentage of Downloaded from https://academic.oup.com/ndt/article-abstract/14/6/1398/1831933 by guest on 20 February 2019 creatinine clearance. Reabsorption rates of Na+ and water at tubular sites were calculated using the formulae quoted in Kusaka et al. [10] .
Histological examination of the left kidney was also made 24 h after reperfusion. The renal tissue was fixed in 10% buffered formalin solution. Later, the kidney was dehydrated in alcohol, blocked in paraffin wax and 5-mm-thick sections were cut and stained by periodic acid-Schiff reaction. Light microscopy (LM ) evaluations were made so those acute tubular lesions were graded on a scale from 0 to 4+ according to the degree of severity: The severity of congestion, i.e. the accumulation of red blood cells in glomeruli, peritubular capillaries and intrarenal veins, was graded on a scale from 1+ to 3+ as described by Mandal et al. [11] . The presence of tubular dilatation, cast formations, mononuclear infiltration and interstitial oedema was noted with 1, and their absence with 0. Vascular changes (in arterial vessel walls) were graded according to a scoring system proposed by Mandal and co-workers [12] . The sum of these changes was the histopathological score for comparison between the groups.
Two independent investigators made histological evaluations; if their assessment disagreed, consensus was reached by discussion, whereas for the histopathological score the mean value was calculated for each group.
In the remaining rats from each group (n=8), PRA levels were measured. To determine PRA, animals were guillotined Fig. 1 . (A) Experiment outlined; (B) systolic blood pressure during and blood samples collected into chilled, siliconized, centri-4 or 8 weeks before induction of ARF in: control rats, -NAME fuge tubes containing Na 2 EDTA (2 mg/ml ). REN-CT2 treated rats, -arginine treated rats and rats treated first with -angiotensin I radioimmunoassay (RIA) kit (CIS Bio NAME and then with -arginine. International, France), were used in radioimmunoassay procedures.
arginine, systolic blood pressure was significantly higher during the treatment with -NAME and then Statistical analyses decreased slowly in the period when the rats received -arginine reaching the control level at the end of the Results are expressed as mean±SEM. One-way analysis of treatment ( Figure 1B ). variance (ANOVA) was applied. When the ANOVA results Ach had a vasorelaxant effect. The effect was generwere significant, Bonferroni's t-test was used to determine ally dose dependent, except for the greatest dose in the the level of significance where a P-value <0.05 was considered to be significant (Primer of Biostatistics, by Stanton control group and the group pretreated with -arginine.
A. Glanz).
It can be clearly seen in Fig. 2A that the vasorelaxant effect in rats pretreated with -NAME is considerably less than (and significantly different from) the effect in Results all other groups. However, in rats pretreated first with -NAME and then with -arginine, the effect is clearly pronounced and strongly dose dependent. Treatment with -NAME, -arginine or both had no influence on body mass. The systolic blood pressure Blood pressure during ARF-induction is shown in Fig. 2B . MAPs before and after clamping are not was significantly higher 1 week after the beginning of treatment with -NAME and was still elevated by the significantly different. After the moment of clamping the pressure decreased insignificantly in the rats of all end of the experiment, whereas in the groups not receiving NO synthesis inhibitor systolic blood pressure groups, and above all in rats pre-treated with -NAME. remained unchanged ( Figure 1B ). In the -argininetreated rats, systolic blood pressure was slightly
The systemic haemodynamic parameters, SHP (MAP, CO and TVR) for all groups are summarized lowered only 4 weeks after the beginning of the treatment. In the group treated with both -NAME and -in Figure 3 . Several points are important to note: Fig. 3 . Mean blood pressure, cardiac output (CO) and total vascular resistance ( TVR) in: sham-operated rats, control rats with acute renal failure (4 weeks -ARF ), -NAME-treated ARF rats, -arginine treated ARF rats, rats treated first with -NAME and then with -Arg (-NAME + -Arg + ARF group), and in rats of the (8 weeks -ARF ) group, serving as a control for the last group; *P<0.05 compared with sham-operated rats; §P<0.05 compared with respective ARF control. Fig. 2. (A) Concentration-response to acetylcholine (Ach) in: control rats, -NAME treated rats, -arginine treated rats and rats treated first with -NAME and then with -arginine. (B) Mean blood -arginine induced, however, a significant increase in pressure during ARF-induction in: sham-operated rats, control rats with acute renal failure (4 weeks -ARF ), -NAME-treated ARF the RBF after ARF, in comparison with all other rats, -arginine treated ARF rats, rats treated first with -NAME groups with ARF. Moreover, the RBF rose by 27% in and then with -Arg (-NAME+-Arg+ARF group), and in rats the -Arg+ARF group with respect to the shamof the (8 weeks -ARF ) group, serving as a control for the last group. operated group. The RVR was lowered slightly in this group, in comparison with the control groups with ARF and the sham-operated group, and was reduced (i) the SHP were not altered 24 h after reperfusion in either control group with ARF when compared with markedly, compared with the -NAME+ARF group ( Figure 4) . the sham-operated rats; (ii) in neither the -Arg+ARF group nor in the -NAME+L-Arg+ARF group was Biochemical parameters are shown in Table 1 . No significant differences in plasma sodium concentration the SHP improved; (iii) treatment with -NAME noticeably increased the MAP and TVR in comparison were found between the groups. There was an increase in plasma potassium concentration in all groups 24 h with all other groups.
Changes in haemodynamic parameters in the renal after renal ischaemia when compared with the shamoperated group. In the -NAME+ARF group the artery are shown in Figure 4 . After the induction of ARF, in both control ARF groups (4 weeks-ARF and increase in plasma concentration of K+ was significantly higher compared with the relevant 4 weeks-ARF 8 weeks-ARF ) the RBF was reduced by 35% compared with the sham-operated animals, but the difference was control group. Creatinine clearance decreased in all groups after AFR, but there were no significant differnot significant. The renal vascular resistance (RVR) was slightly higher after inducing ARF in both control ences among the groups. Fractional excretion of Na+ and K+ increased 24 h after renal ischaemia in all ARF groups. -NAME-induced inhibition of NO synthesis caused a significant decrease of the RBF in those groups. The highest increase in fractional excretion of sodium was observed in the -NAME+ARF group. animals, compared with that of sham-operated rats; and a significant increase of the RVR, in comparison The reabsorption rate of water was reduced in all groups with ARF. However, this reduction was not with all other groups. Stimulation of NO synthesis by 
renal ischaemia and a large decrease was comparison with all other groups with ARF observed after inhibition of NO synthesis.
( Figure 5A ). Moreover, there was no significant morphological difference between this group and the shamoperated group. However, the -NAME+ARF group had significant tubulointerstitial, arteriolar and glomerular lesions. Tubulointerstitial lesions in this group were widespread and intensive and they were characterized by extensive tubular necrosis in the corticomedullar area ( Figure 6A ). In addition, dilatation of lumina of distal tubuli with huge PAS positive tubular casts was also found to be characteristic of the -NAME+ARF group. In contrast, in the -arginine+ARF group only the swelling of proximal tubular cells and different degrees of interstitial oedema were found ( Figure 6B ). Concerning glomeruli, the -NAME+ARF group had the most prominent morphological changes. We noticed an increase in both the mesangial matrix and cells in all glomeruli, and in addition, in some glomeruli we revealed mesangial sclerosis or fibrinoid necrosis ( Figure 6A ). In the -NAME group without ARF, minor abnormalities of glomeruli were detected, such as a slight increase of the mesangial matrix with or without mesangial cell proliferation. These findings are correlated with those on the morphology of blood vessels. However, the glomeruli of the -arginine group were almost indistinguishable from those of the sham-operated group. A slight increase of mesangial cell proliferation is rarely observed in this group ( Figure 6B ). The blood vessels of rats treated with -NAME after inducting ischaemic ARF showed a wide range of morphological changes; from minor ones such as swelling and proliferation of myointimal cells, to extensive ones such as fibrinoid necrosis ( Figure 7A ). Before ARF was induced the rats pretreated with -NAME had some evident mor- Fig. 4 . Renal blood flow (RBF ) and renal vascular resistance (RVR) phological abnormalities of the blood vessels, such as in: sham-operated rats, control rats with acute renal failure (4 vacuolization of myointimal cells, foam transformation weeks -ARF ), -NAME-treated ARF rats, -arginine treated ARF of media, or even myoelastofibrosis in two cases. Thus, rats, rats treated first with -NAME and then with -Arg (-the blood vessel lesions in -NAME rats were more NAME + -Arg + ARF group), and in rats of the (8 weeks -ARF ) group, serving as a control for the last group. pronounced after ARF than before it. In -arginine- Table 1 . Biochemical parameters in: sham operated rats, control rats with ARF (after 4 and 8 weeks), -NAME treated rats with ARF, -arginine-treated rats with ARF and rats with ARF, treated with both -NAME and -arginine of angiotensin I (ANG I ) in: sham-operated rats, control rats with acute renal failure (4 weeks -ARF ), -NAME -treated rats before and after ARF, -arginine treated ARF rats, rats treated first with -NAME and then with -Arg (-NAME + -Arg + ARF group), Ref.
[13]). What we have found is a considerably and in rats of the (8 weeks -ARF ) group, serving as a control for weaker response to Ach in rats pretreated with -the last group. NAME. This can be taken as a strong indication of the NO synthesis inhibition in -NAME-pretreated treated rats slight necrotic arteriolar lesions were rarely animals. However, even though the response was weak detected ( Figure 7B) . it did not disappear completely because Ach may act Figure 5B shows that 24 h after ARF the plasma on the endothelium in ways that are not NO synthaseconcentration of angiotensin I (ANG I ) was slightly dependent, such as by releasing the endothelial-derived but non-significantly higher in the 4 weeks-ARF rats hyperpolarizing factor (EDHF ). when compared with the sham-operated rats. The
Our results have shown that long-term stimulation treatment with -NAME was not accompanied by any of NO release by -arginine improves renal haemosignificant alteration in the plasma concentration of dynamic parameters in the ischaemic form of ARF, ANG I, while in the group treated with -arginine, whereas they are worsened by the inhibition of NO PRA had a tendency to fall in relation to the relevant synthesis. We also showed that this aggravation 4 weeks-ARF control group. As for the -NAME+L-provoked by -NAME can be reversed by -arginine. Arg+ARF group, the circulating level of ANG I was These observations parallel those of Rivas-Cabañ ero not different when compared with the respective 8 et al. [13] 
Discussion
in toxic ARF, produced in rats with uranyl nitrate. Chintala and co-workers [17] found that acute inhibition of endothelial-derived relaxing factor To test the view that chronic administration of -NAME inhibits NO synthesis, we examined the vaso-( EDRF ) aggravates ischaemic acute renal failure in anesthetized rats. The experimental protocol in their relaxant effect of Ach (this effect is often used as an indicator of NO synthase activity, for example experiments was similar to ours. However, they admin- This study has shown, however, that renal haemodynamic alterations induced by ARF, where NO synthesis was inhibited by -NAME, were worse than those induced by ARF alone. The aggravation of the ischaemia-induced renal vasoconstriction caused by -NAME suggests that endogenous NO is functionally present and may be an important mediator regulating renal haemodynamic parameters in ARF. Conger et al. [20] demonstrated that endothelium-dependent relaxation is clearly impaired after ischaemia. In a recent publication [21] however, these authors concluded that NOS/NO activity is in fact highest above baseline 1-week after norepinephrine-induced ARF and cannot be increased further by exogenous stimuli of NOS activity. Schramm et al. [15] suggested that renal ischaemia, which injures endothelial cells, reduced the production of NO in them. On the contrary, Chintala et al. [17] summarized that synthesis of EDRF is probably turned on maximally by the ischaemic insult because treatment with -arginine resulted in only a modest improvement of RPF and GFR in the ischaemic kidney. In our study however, long-term treatment with -arginine resulted in a marked increase in the renal blood flow 24 h after renal ischaemia. Namely, RBF became increased by 96% in the -arginine-treated rats with ARF compared with the group with ARF alone (Figure 4 ). This strongly suggests that release of NO does not reach its maximum treatment, and is lowest in -arginine-pretreated rats with ARF. This is because C CRE is not a suitable indicator of glomerular filtration in rats treated with istered an NO synthase inhibitor (NG-monomethyl--arginine, -NMMA) or NO precursor (-arginine), or -arginine (and only in them) since creatinine arises as a waste product in the decay of -arginine. However, both of them in an infusion that started 30 min before the occlusion of the left renal artery ( lasting 40 min) it seemed almost inconceivable to add a more appropriate method, e.g. determination of inulin clearance, and continued throughout the experiment (220 min). The authors found that NO synthesis inhibition exacer-to our procedure, which was already very difficult for the animals. bated ischaemia-induced changes in renal function, whereas the infusion of -arginine resulted in improved From definitions of the reabsorbtion rates of Na and water, stems the idea that an increase in creatinine renal plasma flow (RPF ) and glomerular filtration rate (GFR) in the ischaemic kidney.
clearance increases both of them. This means that they are actually both greater in ARF rats treated with -In our experiments chronic application of -NAME, 4 weeks before the induction of ARF, resulted in a arginine than their values calculated by using measured creatinine clearance. Nevertheless, the reabsorption significant rise in systolic blood pressure, as described previously by Baylis et al. [18] and Oliviera et al. [19] , rate of water and Na+ was higher in ARF rats treated with -arginine than in -NAME-treated rats with suggesting that -NAME was effective in inhibiting NO synthesis.
ARF ( Table 1) . Moreover, the reabsorption rate of water in the -arginine group was not different comInduction of ARF did not significantly alter the systemic haemodynamic parameters (SHP). In the pared with the sham-operated group. These effects of -arginine are most likely produced by stimulating ARF group treated with -NAME, MAP and TVR increased, while CO had a tendency to decrease reabsorption of water and Na+ at the tubular site.
This hypothesis was substantiated by histopathological ( Figure 3) . However, the same changes of those parameters were observed in the -NAME-treated rats findings in the -arginine group where only swelling of the proximal tubular cells was observed (Fig. 6B ). without ARF (unpublished data). In neither group, i.e. the -Arg+ARF and the -NAME+-Arg+ARF, Along the same lines, Negita and co-workers [22] reported that vacuolization and desquamation of epiwere the SHP improved. It can be concluded that ARF does not modify the effects of EDRF/NO pathway thelial cells from the renal tubules were slight 24 h after reperfusion in groups treated with -arginine or To conclude, acute post-ischaemic renal failure may be alleviated by administering the NO substrate (-sodium nitroprusside compared with those in the control ARF group and the group treated with -NAME. arginine) and NO acts cytoprotectively in ischaemiareperfusion injury of rat kidneys. In this study, the left renal artery and vein were clamped for 90 min and the animals were treated either
The improvement in the course of ARF due to the administration of -arginine observed in this study with a NO synthesis inhibitor or with two stimulators during various periods before reperfusion.
implies that the administration of the NO synthesis donor to patients with ARF would yield a favourable Previous studies have indicated that there is a growing ambiguity about the role of NO and its metabolic effect.
However, all parameters of the ARF are obviously product peroxinitrite (ONOO−) in the pathophysiology of ARF. ONOO− is thought to mediate the toxic worse in rats with chronic inhibition of the NO synthesis. This indicates that a considerably poorer course action of NO and superoxide anion in hypoxia-reperfusion injury of different organs, including the kidney of ARF can be expected in all diseases in which either synthesis and/or action of NO is decreased chronically. [23] . But the efficiency of peroxinitrite-dependent reactions was found to be highest at equimolar concentra-Further support for this conclusion comes from morphological changes, found in kidneys, in the group tions of O 2 − and NO, which suggested that an excess of either reactant could protect against peroxinitrite in treated with -NAME before induction of ARF: minor abnormalities of glomeruli, vacuolization of myointivivo [24] . This finding lead Bartosz [24] to conclude that the common opinion ('small amounts of NO are mal cells and foam transformation of blood vessel media. When ARF is induced in the group pre-treated beneficial while large amounts of NO are toxic') should be revised since higher doses of NO may suppress with -NAME, however, morphological changes in all renal structures are much stronger than in the group peroxinitrite reactions. Xia et al. [25] experimented with NOS-transfected human renal tubular epithelial with ARF only. This also may contribute to the understanding of the high mortality in ARF. cells and found that elimination of -arginine from the medium resulted in ONOO− production and cell Numerous authors who investigated mechanisms of NO activity have shown [27, 28] that NO plays an injury. However, some experiments in vitro showed that two NO synthesis inhibitors, -NAME and -important role in the regulation of endocrine functions (e.g. control of the secretion of pancreatic, hypothal-NMMA, protected renal tubular epithelium against hypoxic injury. Nevertheless, the results obtained in amic, pituitary and other hormones). It was shown that NO inhibits the synthesis of endothelin [29] . experiments in vivo showed the opposite. Namely, administration of nonselective NO synthesis inhibitors Nevertheless, our previous experiments suggested that NO is not involved in endothelin release caused by further compromised renal function in various models of ARF in vivo [13, 17, 22] . Noiri et al. [26 ] reasoned ARF [30] . Evidence is also emerging that NO contributes to the regulation of the secretion of renin, which that the existing uncertainty about the role of NO in ARF is in part due to a lack of selective NOS inhibitors. was among the topics of our investigation.
The data obtained in our study show that plasma These authors found that in vivo targeting of inducible NOS (iNOS ) with oligodeoxynucleotides protects rat concentration of ANG I was increased nonsignificantly 24 h after ARF. The plasma renin activity kidney during ischaemia. When the function of all isoforms of NOS is blocked (as with non-selective has been repeatedly shown to be increased in the initial stages of both clinical and experimental forms of ARF inhibitor), the authors concluded, the deleterious consequences of inhibiting endothelial constitutive NOS [5, 7] . Although these observations are consistent with the possibility that the renin-angiotensin system (RAS ) invariably prevail over the possible benefits of inhibiting iNOS. Taken together, these findings, imply that is involved in ARF, they do not establish a causal connection between the activation of the RAS and the the degree of injury is linked to the iNOS, while restoration of renal function after noxious stimuli subsequent development of ARF. Furthermore, it has been shown that the PRA may return to the control depends on constitutive NOS.
The present communication is the first report about level although ARF still continuous to persists [31] . The effects of NO on renin release and intrarenal post-ischaemic ARF after a long-term NO release stimulation or inhibition. Our main finding is that, formation of ANG II remain controversial [32] . Reid and Chiu [33] quoted some studies, their results sugbesides the improvement of renal haemodynamic parameters, treatment with -arginine reduces tubular cell gesting a stimulatory role for the -arginine-NO pathway in the control of renin secretion. However, under injury in acute post-ischaemic renal failure. This is most clearly seen in observing tubular epithelial cell different circumstances (e.g. after long-term treatment) blockade of NO synthesis increases renin secretion. morphology in rats treated with -arginine: the changes found were subtle ( Figure 6B ).
The development of hypertension in Sprague-Dawley rats, produced by chronic treatment with -NAME However, we found most prominent lesions in the -NAME+ARF group: large areas of corticomedullar depends on intactness of RAS, but -NAME can clearly increase blood pressure independent of any necrosis and heavy damage of the tubular epithelial cells with a lot of intratubular casts. But, this aggrava-involvement of ANG II, concluded Melaragno et al. [34] . An apparent inconsistency in the abovetion of changes in renal morphology can be reversed by -arginine. mentioned reports may be resolved if a dual effect of NO on renin release is assumed. After an initial haemodynamics in the -arginine treated group with ARF. transient inhibitory effect, there appears to be a delayed but sustained stimulatory effect on renin formation
